Mycea is gaining recognition in the Ag Biotech ecosystem for its innovative approach to crop protection using forest fungi extracts.
Les Échos Coverage – December 1, 2025
“Mycea uses mushroom extracts to protect crops from diseases”
Les Échos, France’s leading business newspaper, features Mycea’s mission to develop natural biocontrol solutions from forest fungi. The article explores our scientific approach, our lead candidate approaching regulatory phases, and our upcoming fundraising round.
About Our Innovation
Mycea has built a proprietary collection of over 750 wild forest fungal species, systematically explored for their potential in crop disease control. After seven years of rigorous lab and field testing, we’ve identified a lead extract candidate with exceptional efficacy against multiple crop diseases at very low doses. This extract is produced in bioreactors where our team has optimized both the cultivation process and extraction methods to ensure industrial-scale viability at competitive pricing.
Why Now
As Europe progressively withdraws toxic chemical fungicides from the market, farmers urgently need effective, safe alternatives. Mycea’s natural solutions address this critical gap while meeting the economic and agronomic requirements of a more resilient agriculture.
Leadership
Mycea is co-led by:
– Dominique Barry-Etienne, co-founder and CEO Science & Technology (founded 2018)
– Aline Bsaibes, CEO Business & Partnerships (former CEO of ITK, French Agtech pioneer)
“We are looking for a combination of three criteria: effectiveness against a wide range of diseases, non-toxicity, and the ability to produce at scale with competitive pricing,” explains Aline Bsaibes in the article.
Next Steps
Mycea is preparing a new funding round to advance its lead candidate through regulatory approval in Europe and South America, with a goal to bring effective biocontrol solutions to farmers through industrial partnerships.
